Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Advances

Author: Almaz OhenePublished: 11 November 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Cambridge Uni

A ‘state-of-the-art’ University of Cambridge chemistry facility, specialising in Parkinson’s disease research, is set to open in 2017

The world-renowned University of Cambridge has received the green light for plans to build a £22m chemistry facility, which will be its new headquarters for research into Parkinson’s disease, type 2 diabetes and Alzheimer’s disease.

The Chemistry of Health Centre will house a Chemistry of Health Incubator “with research scientists from industrial partners and start-ups occupying laboratory and desk space alongside academics from Cambridge and collaborating institutions,” according to minutes printed in the University Reporter weekly bulletin.

The report also stated that the research centre “will enable the Department of Chemistry’s Centre for Protein Misfolding Diseases to combat modern pandemics such as Parkinson’s disease”.

The building will also include a Molecular Production and Characterisation Centre, which will provide support and access to state-of-the-art instrumentation for academic and industry researchers from across the UK.

The building works are expected to begin in March 2016 and the centre is due to open in late 2017.

The estimated project cost of £22m will be met by a £17m grant from the Higher Education Funding Council for England and £5m in philanthropic donations.

Go Back

Share this story

Comments


Related articles


Young woman sleeping in bed beside the window

Carers' Corner

How my husband’s Parkinson’s has ruined our sex life

A candid account of sex life and Parkinson’s

READ MORE
Tonya Walker Romwe Dress-1

Perspectives

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

This season’s off the shoulder trend hides DBS surgery scars

READ MORE
Parkinson's Life voxpops video

Perspectives

VIDEO: What do you know about Parkinson’s disease?

We took to the streets to find out how much the public knows

READ MORE